-
公开(公告)号:EP4062942A1
公开(公告)日:2022-09-28
申请号:EP21163944.8
申请日:2021-03-22
IPC分类号: A61K47/54 , A61K47/55 , C07D275/04 , A61P35/00 , A61P37/00
摘要: The present application relates to a compound having the formula (I)
A-L-B (I)
wherein
A is represented by
L is a bond or a self-immolative spacer;
B is represented by
The compound is capable of releasing molecular cargo in the presence of a reductase and is thus suitable for treating, ameliorating, preventing or diagnosing a disorder selected from a neoplastic disorder; atherosclerosis; an autoimmune disorder; an inflammatory disease; a chronic inflammatory autoimmune disease; ischaemia; and reperfusion injury.